Wikidata entity: Q65332950
Quantities
| P4135 | maximum age | 89 |
| P2899 | minimum age | 50 |
| P1132 | number of participants | 28 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2017-09-28 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q83030 (dementia) | dementia |
| P4844 | research intervention | ... | Q415081 (donepezil) | donepezil |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270309 (Premiere Research Institute) | Premiere Research Institute |
| P1813 | short name | Monolingualtext | CPC-12 | ??? |
| P580 | start time | ... | 2015-10-07 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Phase II, Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type | ??? |
| P3098 | ClinicalTrials.gov ID | NCT02549196 |
Why not click here or view trends?
log id: 4452333